🇺🇸 FDA
Pipeline program

Study of BGB-11417 in Patients with Mature B Cell Malignancies

BGB-11417-101

Phase 1 other active

Quick answer

Study of BGB-11417 in Patients with Mature B Cell Malignancies for Mature B Cell Malignancies is a Phase 1 program (other) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
BEONE MEDICINES AUS PTY LTD
Indication
Mature B Cell Malignancies
Phase
Phase 1
Modality
other
Status
active

Clinical trials